Advancements in Oral Solid Dosage: Innovations Shaping the Future of OSD Pharmaceuticals

Tuesday, March 18, 2025

The pharmaceutical industry continues to evolve rapidly, with oral solid dosage (OSD) formulations remaining at the forefront of drug delivery innovation. As we look towards the future, the OSD market is poised for significant growth, driven by technological advancements, changing patient needs, and a shifting regulatory landscape. This article explores the current state and future prospects of the OSD pharmaceutical market, examining key trends, market size, technological breakthroughs, and regulatory developments that are shaping this critical sector of the healthcare industry.

Market Overview and Growth Projections

The global oral solid dosage pharmaceutical formulation market has been experiencing steady growth, with projections indicating continued expansion in the coming years. In 2023, the market was valued at USD 727.77 billion, and it is expected to reach USD 1176.32 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.1%.1 This growth trajectory underscores the enduring popularity and efficacy of OSD formulations in treating a wide range of acute and chronic conditions.

Another market analysis provides a slightly different perspective, estimating that the global OSD pharmaceutical market will top USD 1.03 trillion by 2032, expanding at a CAGR of 6.4% from 2022 to 2032.6 The variance in these projections highlights the dynamic nature of the market and the potential for fluctuations based on various factors, including technological advancements, regulatory changes, and global health trends.

The OSD contract manufacturing market, a crucial segment of the broader OSD market, was estimated at USD 36.50 billion in 2023 and is projected to grow at a CAGR of 5.97% from 2024 to 2030.9 This growth in contract manufacturing reflects the increasing trend of pharmaceutical companies outsourcing production to specialized facilities, allowing for greater efficiency and focus on core research and development activities.

Technological Trends Driving Innovation

The OSD pharmaceutical sector is witnessing a surge in technological innovations aimed at enhancing drug efficacy, improving patient compliance, and streamlining manufacturing processes. Several key trends are shaping the future of OSD formulations:

  1. Advanced Drug Delivery Systems: Manufacturers are increasingly focusing on developing modified-release (MR) oral solid dosage solutions. These formulations can sustain therapeutic blood concentrations for extended periods, potentially reducing dosing frequency and improving patient adherence6. The adoption of controlled-release and sustained-release technologies is expected to drive market growth in the coming years.
  2. Personalized Medicine Approaches: The industry is moving towards more patient-centric formulations, with a growing emphasis on personalized medicine. This trend is supported by advancements in predictive modeling and artificial intelligence, allowing for more precise dosing and formulation strategies tailored to individual patient needs.2
  3. Integration of Digital Health Technologies: The incorporation of digital health technologies into OSD formulations is gaining traction. This integration can enhance patient monitoring, improve adherence, and provide valuable data for healthcare providers and pharmaceutical companies alike.3
  4. 3D Printing in OSD Manufacturing: The potential integration of 3D printing technology in OSD manufacturing represents a significant breakthrough. This technology offers the possibility of precise control over drug release profiles and the ability to customize dosage forms based on individual patient requirements. The flexibility in drug design and manufacturing provided by 3D printing could revolutionize the production of complex shapes and formulations.9
  5. Artificial Intelligence and Machine Learning: The application of AI and ML in drug formulation and development is accelerating. These technologies are being used to streamline decision-making processes, evaluate technologies and excipients, and enhance bioavailability and solubility with greater accuracy. This data-driven approach is helping companies avoid trial-and-error cycles and solve common drug development challenges more efficiently.2

Market Trends and Drivers

Several key factors are driving the growth and evolution of the OSD pharmaceutical market:

  1. Increasing Demand for Personalized Medicine:  The shift towards personalized therapeutic approaches is a significant driver of market growth. This trend is pushing manufacturers to develop more sophisticated and tailored OSD formulations.3
  2. Focus on Biopharmaceuticals: There is a growing emphasis on developing oral solid dosage forms for biopharmaceuticals, including peptides, proteins, and monoclonal antibodies. This focus on expanding the range of molecules that can be delivered orally is opening new avenues for market growth.2
  3. Expansion into Emerging Markets: Pharmaceutical companies are increasingly looking to expand their presence in emerging markets, driving demand for cost-effective and easily transportable OSD formulations.3
  4. Rise of Telemedicine Services: The proliferation of telemedicine services is influencing the OSD market, with a growing need for formulations that are suitable for remote patient care and management.3
  5. Emphasis on Preventive Healthcare: There is an increasing focus on preventive healthcare strategies, which is driving demand for OSD formulations designed for long-term use in managing chronic conditions and preventing disease progression.3

Regulatory Trends and Challenges

The regulatory landscape for OSD pharmaceuticals continues to evolve, presenting both challenges and opportunities for manufacturers:

  1. Stringent Quality Standards: Regulatory bodies are imposing increasingly stringent quality standards for OSD formulations, particularly in light of the growing complexity of formulations and the use of highly potent active pharmaceutical ingredients (HPAPIs).7
  2. Focus on Patient Safety: There is a heightened regulatory focus on ensuring patient safety, particularly in the context of novel formulations and delivery systems. This includes rigorous requirements for demonstrating bioequivalence and assessing potential side effects.7
  3. Harmonization of Global Regulations: Efforts to harmonize regulatory requirements across different regions are ongoing, aimed at streamlining the approval process for OSD formulations in multiple markets.3
  4. Environmental Considerations: Regulatory bodies are increasingly considering the environmental impact of pharmaceutical manufacturing and disposal, potentially leading to new requirements for sustainable production practices and packaging.3 

Breakthrough Technologies

Several breakthrough technologies are poised to revolutionize the OSD pharmaceutical sector:

  1. Nanotechnology in Drug Delivery: The application of nanotechnology in OSD formulations is enabling enhanced drug solubility, improved bioavailability, and targeted delivery of active ingredients.2
  2. Continuous Manufacturing: The adoption of continuous manufacturing processes for OSD production is gaining traction, offering benefits such as improved efficiency, reduced costs, and enhanced quality control.9
  3. Smart Pills: The development of “smart pills” incorporating sensors and communication technologies is opening new possibilities for monitoring patient adherence and drug efficacy.3
  4. Bioprinting: Advances in bioprinting technology are enabling the creation of complex, multi-layered OSD formulations with precise control over drug release profiles.9

Market Outlook and Future Prospects

The future of the OSD pharmaceutical market looks promising, with several factors contributing to its continued growth and evolution:

  1. Aging Population: The growing elderly population worldwide is expected to drive demand for OSD formulations, particularly for chronic disease management.8
  2. Technological Advancements: Ongoing innovations in drug delivery technologies, manufacturing processes, and formulation techniques are likely to expand the capabilities and applications of OSD formulations.9
  3. Increasing R&D Investment: Pharmaceutical companies and contract manufacturers are investing heavily in research and development, focusing on novel OSD formulations and manufacturing technologies.9
  4. Expansion of Contract Manufacturing: The trend towards outsourcing OSD manufacturing is expected to continue, driving growth in the contract manufacturing segment of the market.9
  5. Focus on Emerging Markets: The expansion of pharmaceutical companies into emerging markets is likely to create new opportunities for growth in the OSD sector.3

In conclusion, the oral solid dosage pharmaceutical market is poised for significant growth and transformation in the coming years. Driven by technological innovations, changing patient needs, and evolving regulatory landscapes, the sector is witnessing a shift towards more sophisticated, personalized, and efficient formulations. As manufacturers continue to invest in research and development, and as new technologies such as 3D printing and nanotechnology mature, we can expect to see increasingly advanced OSD formulations that offer improved efficacy, enhanced patient compliance, and more targeted therapeutic outcomes. The challenges posed by regulatory requirements and the need for sustainable practices will continue to shape the industry, pushing manufacturers to innovate and adapt. With its enduring popularity and proven effectiveness, oral solid dosage remains a cornerstone of pharmaceutical delivery, poised to play a crucial role in addressing global health challenges and improving patient care in the years to come.

Citations

  1. https://www.maximizemarketresearch.com/market-report/oral-solid-dosage-pharmaceutical-formulation-market/121388/
  2. https://themedicinemaker.com/manufacture/trends-and-technologies-in-oral-solid-dosage-formulation
  3. https://www.researchandmarkets.com/report/global-oral-solid-dose-market
  4. https://www.transparencymarketresearch.com/global-oral-solid-dosage-pharmaceutical-formulation-market.html
  5. https://www.contractpharma.com/oral-solids-market-technology-trends/
  6. https://www.factmr.com/report/oral-solid-dosage-pharmaceutical-market
  7. https://themedicinemaker.com/discovery-development/three-trends-to-watch-in-oral-solid-dosages
  8. https://www.futuremarketinsights.com/reports/oral-solid-dosage-pharmaceutical-formulation-market
  9. https://www.grandviewresearch.com/industry-analysis/oral-solid-dosage-osd-contract-manufacturing-market-report
  10. https://www.pharmtech.com/view/examining-trends-in-oral-solid-dosage-manufacturing
  11. https://www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html
  12. https://www.tabletscapsules.com/3641-Technical-Articles/617375-2025-Predictions-Industry-Leaders-Weigh-in-on-the-Future-of-Oral-Solid-Dose/
  13. https://www.globenewswire.com/news-release/2024/03/13/2845621/28124/en/Global-Oral-Solid-Dosage-Contract-Manufacturing-Market-2024-2030-Regional-Trends-for-Tablets-Capsules-Powders-and-Granules.html

About the Author

Mike Auerbach, Group Editor-in-Chief, Pharma Group, American Pharmaceutical Review

Publication Detail

This article appeared in American Pharmaceutical Review - Innovations at Interphex 2025 Supplement 
Pages: 16-18

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from American Pharmaceutical Review delivered to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion